TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
MNPR

Monopar Therapeutics Inc

Healthcare · Biotechnology

85.20$ -4.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Monopar Therapeutics Inc (MNPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 135 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MNPR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
8.6 7.3 8.9 7.2 6.1 60 55 54 144 141 138 135
8.6 7.3 8.9 7.2 6.1 60 55 54 144 140 138 135
5.5 7.3 7.8 6.1 6.0 46 40 40 128 62 53 53
8.5 7.3 8.8 7.1 6.0 60 55 53 144 140 137 134
2.0 1.8 1.4 1.1 1.1 5.3 1.5 1.7 2.6 2.9 2.6 4.1
2.0 1.8 1.4 1.1 1.1 5.3 1.5 1.6 2.6 2.7 2.5 4.0
– – – – – – – – 0.0 – – –
2.0 1.8 1.4 1.1 1.1 2.3 1.5 1.6 2.5 2.7 2.5 4.0
6.6 5.6 7.5 6.1 4.9 55 54 52 142 138 135 131
-58 -60 -62 -64 -65 -76 -78 -81 -84 -90 -93 -99
14 15 16 18 11 11 7.0 7.0 7.1 6.7 8.5 8.5

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?